Envoy Medical Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021
Cash & Equivalents	4.22	0.18	1.12
Cash & Cash Equivalents	4.22	0.18	1.12
Cash Growth	2204.92%	-83.68%	-
Receivables	0.25	0.04	0.09
Inventory	1.4	1.3	1.06
Other Current Assets	0.96	0.13	0.17
Total Current Assets	6.83	1.65	2.44
Property, Plant & Equipment	0.82	0.91	0.19
Total Long-Term Assets	0.82	0.91	0.19
Total Assets	7.64	2.56	2.62
Accounts Payable	1.55	1	0.66
Current Debt	0.16	0.57	0
Other Current Liabilities	4.92	0.94	0.72
Total Current Liabilities	6.64	2.52	1.38
Long-Term Debt	0.4	33.96	23.48
Other Long-Term Liabilities	2.36	2.27	2.75
Total Long-Term Liabilities	2.77	36.23	26.23
Total Liabilities	9.4	38.75	27.61
Total Debt	0.56	34.54	23.48
Debt Growth	-98.37%	47.10%	-
Retained Earnings	-257.24	-225.99	-210.06
Comprehensive Income	-0.12	-0.12	-0.11
Shareholders' Equity	-1.76	-36.2	-44.96
Net Cash / Debt	3.66	-34.35	-22.36
Net Cash Per Share	0.29	-3.39	-0.16
Working Capital	0.19	-0.87	1.05
Book Value Per Share	-0.14	-3.58	-0.32

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).